| Product NDC: | 50474-700 |
| Proprietary Name: | Cimzia |
| Non Proprietary Name: | certolizumab pegol |
| Active Ingredient(s): | & nbsp; certolizumab pegol |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 50474-700 |
| Labeler Name: | UCB, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125160 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20080420 |
| Package NDC: | 50474-700-61 |
| Package Description: | 2 KIT in 1 CARTON (50474-700-61) > 1 KIT in 1 KIT * 1 mL in 1 VIAL, GLASS * 1 mL in 1 VIAL, GLASS |
| NDC Code | 50474-700-61 |
| Proprietary Name | Cimzia |
| Package Description | 2 KIT in 1 CARTON (50474-700-61) > 1 KIT in 1 KIT * 1 mL in 1 VIAL, GLASS * 1 mL in 1 VIAL, GLASS |
| Product NDC | 50474-700 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | certolizumab pegol |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 20080420 |
| Marketing Category Name | BLA |
| Labeler Name | UCB, Inc. |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |